Topic: eye disease

Spark Therapeutics logo on labcoat

Spark Therapeutics

After launching in late 2013 with $50 million and a clutch of gene therapies out of Children’s Hospital of Philadelphia, Spark Therapeutics hit the gas. It picked up another $73 million and a Big Pharma partner en route to its upsized IPO in 2015.